FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma – A novel validated prognostic score to facilitate treatment decision-making in real-world. 3. September 2022 Marschner N, Hegewisch-Becker S, Reiser M, von der Heyde E, Bertram M, Hollerbach SH, Kreher S, Wolf T, Binninger A, Chiabudini M, Kaiser-Osterhues A, Jänicke M; TPK-Group (Tumour Registry Pancreatic Cancer), 2023. Int J Cancer. 152:458-469. doi: 10.1002/ijc.34271. Epub 2022 Sep 22. Link Sequential treatment patterns over time for advanced renal cell carcinoma – Data from the German research platform CARAT. Goebell, P.J., Grüllich, C., Müller, L., Bögemann, M., Martens, U., von der Heyde, E., Reichert, D., Nusch, A., Schlenska-Lange., A., Wetzel, N., Koska, M., Jänicke,… Weiterlesen FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma – A novel validated prognostic score to facilitate treatment decision-making in real-world. Marschner N, Hegewisch-Becker S, Reiser M, von der Heyde E, Bertram M, Hollerbach SH, Kreher S, Wolf T, Binninger A, Chiabudini M, Kaiser-Osterhues A, Jänicke… Weiterlesen